Associations of MIR-146a and MIR-146b expression and breast cancer in very young women

Cancer Biomarkers

Volumn 15, Issue 6, 2015, Pages 881-887

  Li, Yongqing ^a   Xu, Yadong ^b   Yu, Chundong ^c   Zuo, Wenshu ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b People's Hospital of Haiyang   (China)

^c Center of Hospital of Women and Children of Qingdao City   (China)

Author keywords

Breast cancer; MIR 146a; MIR 146b; RT PCR

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; INTERLEUKIN 6; KI 67 ANTIGEN; MICRORNA; MICRORNA 146A; MICRORNA 146B; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; MIRN146 MICRORNA, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST FIBROADENOMA; CANCER SIZE; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; HUMAN; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOLOGICAL PARAMETERS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YOUNG ADULT; BREAST TUMOR; FOLLOW UP; GENETICS; PATHOLOGY; PROGNOSIS; TUMOR INVASION;

ADULT; BIOMARKERS, TUMOR; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; LYMPHATIC METASTASIS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS;

EID: 84949193318     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-150532     Document Type: Article

References (35)

1. X. Liu, H. Qu, W. Cao, Y. Wang, Z. Ma, F. Li and H. Wang, Efficacy of combined therapy of goserelin and letrozole on very young women with advanced breast cancer as first-line endocrine therapy, Endocr J 60(2013), 819-828.
2. S. Pizzini, A. Bisognin, S. Mandruzzato, M. Biasiolo, A. Facciolli, L. Perilli, E. Rossi, G. Esposito, M. Rugge, P. Pilati, S. Mocellin, D. Nitti, S. Bortoluzzi and P. Zanovello, Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis, BMC Genomics 14(2013), 589.
3. A. Karakatsanis, I. Papaconstantinou, M. Gazouli, A. Lyberopoulou, G. Polymeneas and D. Voros, Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance, Mol Carcinog 52(2013), 297-303.
4. K. Nakata, K. Ohuchida, K. Mizumoto, T. Kayashima, N. Ikenaga, H. Sakai, C. Lin, H. Fujita, T. Otsuka, S. Aishima, E. Nagai, Y. Oda and M. Tanaka, MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis, Surgery 150(2011), 916-922.
5. H. Li, S. Xie, M. Liu, Z. Chen, X. Liu, L. Wang, D. Li and Y. Zhou, The clinical significance of downregulation of mir-124- 3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis, Int J Oncol 45(2014), 197-208.
6. M. L. Burger, L. Xue, Y. Sun, C. Kang and A. Winoto, Premalignant PTEN-deficient thymocytes activate microRNAs miR- 146a and miR-146b as a cellular defense against malignant transformation, Blood 123(2014), 4089-4100.
7. L. Zhou, X. Zhao, Y. Han, Y. Lu, Y. Shang, C. Liu, T. Li, Z. Jin, D. Fan and K. Wu, Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis, FASEB J 27(2013), 4929-4939.
8. I. G. Papaconstantinou, A. Manta, M. Gazouli, A. Lyberopoulou, P. M. Lykoudis, G. Polymeneas and D. Voros, Expression of microRNAs in patients with pancreatic cancer and its prognostic significance, Pancreas 42(2013), 67-71.
9. C. B. Avci, E. Harman, Y. Dodurga, S. Y. Susluer and C. Gunduz, Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells, Asian Pac J Cancer Prev 14(2013), 765-768.
10. J. Zhang, Y. Liu, Z. Liu, X. M. Wang, D. T. Yin, L. L. Zheng, D. Y. Zhang and X. B. Lu, Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma, Int J Med Sci 10(2013), 585-592.
11. S. Huang, R. He, M. Rong, Y. Dang and G. Chen, Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells, Biomed Res Int 2014(2014), 384121.
12. J. Li, H. Yang, Y. Li, Y. Liu, S. Chen, C. Qi, Q. Zhang, T. Lan, X. He, X. Y. Guan and L. Wang, micro-RNA-146 upregulation predicts the prognosis of non-small cell lung cancer by miRNA in situ hybridization, Exp Mol Pathol 96(2014), 195-199.
13. D. R. Hurst, M. D. Edmonds, G. K. Scott, C. C. Benz, K. S. Vaidya and D. R. Welch, Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis, Cancer Res 69(2009), 1279-1283.
14. X. Li, B. Xu, M. S. Moran, Y. Zhao, P. Su, B. G. Haffty, C. Shao and Q. Yang, 53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-kappaB through miR- 146a, Carcinogenesis 33(2012), 2593-2600.
15. D. Wang, D. Liu, J. Gao, M. Liu, S. Liu, M. Jiang, Y. Liu and D. Zheng, TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration, FEBS J 280(2013), 3340-3353.
16. D. Bhaumik, G. K. Scott, S. Schokrpur, C. K. Patil, J. Campisi, C. C. Benz, Expression of microRNA-146 suppresses NFkappaB activity with reduction of metastatic potential in breast cancer cells, Oncogene 27(2008), 5643-5647.
17. J. M. Harvey, G. M. Clark, C. K. Osborne and D. C. Allred, Estrogen receptor status by immuno-histochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer, J Clin Oncol 17(1999), 1474-1481.
18. A. C. Wolff, M. E. Hammond, J. N. Schwartz, K. L. Hagerty, D. C. Allred, R. J. Cote, M. Dowsett, P. L. Fitzgibbons, W. M. Hanna, A. Langer, L. M. McShane, S. Paik, M. D. Pegram, E. A. Perez, M. F. Press, A. Rhodes, C. Sturgeon, S. E. Taube, R. Tubbs, G. H. Vance, M. van de Vijver, T. M. Wheeler and D. F. Hayes, American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, J Clin Oncol 25(2007), 118-145.
19. M. Malleter, C. Jacquot, B. Rousseau, C. Tomasoni, M. Juge, A. Pineau, V. Sakanian and C. Roussakis, miRNAs, a potential target in the treatment of Non-Small-Cell Lung Carcinomas, Gene 506(2012), 355-359.
20. Y. Q. Gu, G. Gong, Z. L. Xu, L. Y. Wang, M. L. Fang, H. Zhou, H. Xing, K. R. Wang and L. Sun, miRNA profiling reveals a potential role of milk stasis in breast carcinogenesis, Int J Mol Med 33(2014), 1243-1249.
21. A. Iyer, E. Zurolo, A. Prabowo, K. Fluiter, W. G. Spliet, P. C. van Rijen, J. A. Gorter and E. Aronica, MicroRNA-146a: A key regulator of astrocyte-mediated inflammatory response, PLoS One 7(2012), e44789.
22. S. Benvenga and C. A. Koch, Molecular pathways associated with aggressiveness of papillary thyroid cancer, Curr Genomics 15(2014), 162-170.
23. P. S. Hung, C. J. Liu, C. S. Chou, S. Y. Kao, C. C. Yang, K. W. Chang, T. H. Chiu and S. C. Lin, miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes, PLoS One 8(2013), e79926.
24. X. Xue, W. Xia and H. Wenzhong, A modeled dynamic regulatory network of NF-κB and IL-6 mediated by miRNA, Biosystems 114(2013), 214-218.
25. K. Zhu, Q. Pan, X. Zhang, L. Q. Kong, J. Fan, Z. Dai, L. Wang, X. R. Yang, J. Hu, J. L. Wan, Y. M. Zhao, Z. H. Tao, Z. T. Chai, H. Y. Zeng, Z. Y. Tang, H. C. Sun and J. Zhou, MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression, Carcinogenesis 34(2013), 2071-2079.
26. X. Ma, L. E. Becker Buscaglia, J. R. Barker and Y. Li, MicroRNAs in NF-kappaB signaling, J Mol Cell Biol 3(2011), 159-166.
27. M. Xiang, N. J. Birkbak, V. Vafaizadeh, S. R. Walker, J. E. Yeh, S. Liu, Y. Kroll, M. Boldin, K. Taganov, B. Groner, A. L. Richardson and D. A. Frank, STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-drivencancer phenotypes, Sci Signal 7(2014), ra11.
28. M. Tanic, M. Zajac, G. Gamez-Lapez, J. Benatez and B. Martanez-Delgado, Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NF?B pathway, Breast Cancer Res Treat 134 (2012), 41-51.
29. D. Bhaumik, G. K. Scott, S. Schokrpur, C. K. Patil, J. Campisi and C. C. Benz, Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells, Oncogene 27(2008), 5643-5647.
30. S. Kumar, R. Keerthana, A. Pazhanimuthu and P. Perumal, Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients, Indian J Biochem Biophys 50(2013), 210-214.
31. U. Berber, I. Yilmaz, G. Narli, A. Haholu, Z. Kucukodaci and D. Demirel, miR-205 and miR-200c: Predictive micro RNAs for lymph node metastasis in triple negative breast cancer, J Breast Cancer 17(2014), 143-148.
32. S. Nam, X. Long, C. Kwon, S. Kim and K. P. Nephew, An integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen - resistant breast cancer cells, BMC Genomics 13(2012), 732.
33. D. R. Hurst, M. D. Edmonds, G. K. Scott, C. C. Benz, K. S. Vaidya and D. R. Welch, Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis, Cancer Res 69(2009), 1279-1283.
34. C. P. El-Haibi, G. W. Bell, J. Zhang, A. Y. Collmann, D. Wood, C. M. Scherber, E. Csizmadia, O. Mariani, C. Zhu, A. Campagne, M. Toner, S. N. Bhatia, D. Irimia, A. Vincent-Salomon and A. E. Karnoub, Critical role for lysyl oxidase in mesenchymal stem cell - driven breast cancer malignancy. Proc Natl Acad Sci USA 109(2012), 17460-17465.
35. F. L. Muehlberg, Y. H. Song, A. Krohn, S. P. Pinilla, L. H. Droll, X. Leng, M. Seidensticker, J. Ricke, A. M. Altman, E. Devarajan, W. Liu, R. B. Arlinghaus and E. U. Alt, Tissue - resident stem cells promote breast cancer growth and metastasis, Carcinogenesis 30(2009), 589-597.